The safety and tolerability of epacadostat alone and in combination with pembrolizumab in patients with advanced solid tumors: results from a first-in-Japanese phase I study (KEYNOTE-434)

被引：0
|
作者：
Toshihiko Doi
Yutaka Fujiwara
Kohei Shitara
Toshio Shimizu
Kan Yonemori
Nobuaki Matsubara
Izumi Ohno
Takahiro Kogawa
Yoichi Naito
Lance Leopold
Mihaela Munteanu
Naoyoshi Yatsuzuka
Shi Rong Han
Ayman Samkari
Noboru Yamamoto
机构：
[1] National Cancer Center Hospital East,Department of Experimental Therapeutics
[2] National Cancer Center Hospital,Department of Experimental Therapeutics
[3] Mitsui Memorial Hospital,Department of Respiratory Medicine
[4] Incyte Corporation,Department of Clinical Oncology
[5] Clinical Development,undefined
[6] MSD K.K. Oncology Science Unit,undefined
[7] Merck & Co.,undefined
[8] Inc.,undefined
来源：
Investigational New Drugs | 2021年 / 39卷
关键词：
Advanced solid tumors; Epacadostat (INCB024360); Japanese; Pembrolizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：152 / 162
页数：10
相关论文
共 50 条
  • [21] Epacadostat plus pembrolizumab in patients with advanced melanoma: Phase 1 and 2 efficacy and safety results from ECHO-202/KEYNOTE-037
    Hamid, O.
    Gajewski, T. F.
    Frankel, A. E.
    Bauer, T. M.
    Olszanski, A. J.
    Luke, J. J.
    Balmanoukian, A. S.
    Schmidt, E. V.
    Sharkey, B.
    Maleski, J.
    Jones, M. J.
    Gangadhar, T. C.
    ANNALS OF ONCOLOGY, 2017, 28
  • [22] A phase I/Ib study of trametinib (GSK1120212) alone and in combination with gemcitabine in Japanese patients with advanced solid tumors
    Akiyoshi Kasuga
    Kazuhiko Nakagawa
    Fumio Nagashima
    Toshio Shimizu
    Daisuke Naruge
    Shinichi Nishina
    Hiroshi Kitamura
    Takayasu Kurata
    Atsuko Takasu
    Yasuhito Fujisaka
    Wataru Okamoto
    Yuichiro Nishimura
    Akihira Mukaiyama
    Hideki Matsushita
    Junji Furuse
    Investigational New Drugs, 2015, 33 : 1058 - 1067
  • [23] A phase I/Ib study of trametinib (GSK1120212) alone and in combination with gemcitabine in Japanese patients with advanced solid tumors
    Kasuga, Akiyoshi
    Nakagawa, Kazuhiko
    Nagashima, Fumio
    Shimizu, Toshio
    Naruge, Daisuke
    Nishina, Shinichi
    Kitamura, Hiroshi
    Kurata, Takayasu
    Takasu, Atsuko
    Fujisaka, Yasuhito
    Okamoto, Wataru
    Nishimura, Yuichiro
    Mukaiyama, Akihira
    Matsushita, Hideki
    Furuse, Junji
    INVESTIGATIONAL NEW DRUGS, 2015, 33 (05) : 1058 - 1067
  • [24] A phase I study of the safety, tolerability and pharmacokinetics of pazopanib (P) in combination with gemcitabine (G) for advanced solid tumors
    Richly, H.
    Rubin, S. D.
    Madi, A.
    Jeffels, M.
    Nokay, B.
    Gibson, D.
    Weller, S.
    Scheulen, M. E.
    Plummer, R.
    EJC SUPPLEMENTS, 2010, 8 (07): : 25 - 25
  • [25] Phase I study of ombrabulin in combination with paclitaxel and carboplatin in Japanese patients with advanced solid tumors
    Matsumoto, Koji
    Sunaga, Yoshinori
    Ecstein-Fraisse, Evelyne
    Fujiwara, Keiichi
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (04) : 586 - 593
  • [26] A phase I/I b study of GSK1120212 (trametinib) alone and in combination with gemcitabine in Japanese patients with advanced solid tumors.
    Kurata, Takayasu
    Furuse, Junji
    Okamoto, Isamu
    Kasuga, Akiyoshi
    Fujisaka, Yasuhito
    Kitamura, Hiroshi
    Shimizu, Toshio
    Takasu, Atsuko
    Okamoto, Wataru
    Naruge, Daisuke
    Nagashima, Fumio
    Katsura, Koichi
    Mukaiyama, Akihira
    Matsushita, Hideki
    Nakagawa, Kazuhiko
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [27] Phase I study to assess the safety and tolerability of olaparib in combination with bevacizumab in patients with advanced solid tumours
    Dean, E.
    Middleton, M. R.
    Pwint, T.
    Swaisland, H.
    Carmichael, J.
    Goodege-Kunwar, P.
    Ranson, M.
    BRITISH JOURNAL OF CANCER, 2012, 106 (03) : 468 - 474
  • [28] Phase I study to assess the safety and tolerability of olaparib in combination with bevacizumab in patients with advanced solid tumours
    E Dean
    M R Middleton
    T Pwint
    H Swaisland
    J Carmichael
    P Goodege-Kunwar
    M Ranson
    British Journal of Cancer, 2012, 106 : 468 - 474
  • [29] Safety, tolerability, pharmacokinetics, and antitumor activity of adavosertib in Japanese patients with advanced solid tumors: A phase I, open-label study
    Kondo, Shunsuke
    Katsuya, Yuki
    Yonemori, Kan
    Komuro, Keiko
    Sugeno, Masatoshi
    Kawata, Toshio
    Ghiorghiu, Dana
    Meulendijks, Didier
    Yamamoto, Noboru
    CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2024, 39
  • [30] Phase I study of GS-5745 alone and in combination with chemotherapy in patients with advanced solid tumors
    Bendell, Johanna C.
    Starodub, Alexander
    Shah, Manish A.
    Sharma, Sunil
    Wainberg, Zev A.
    Thai, Dung Luong
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345